Emmaus Life Sciences, Inc.
EMMA
Revenue
5.38M
▲2.87M▲114.57%
3 Months ChangeAssets
25.94M
▼-3.60M▼-12.20%
3 Months ChangeLiabilities
82.95M
▼-234.00k▼-0.2813%
3 Months ChangeFree Cash Flow
136.00k
▲1.43M▲110.48%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-25
Form 8-K
ID: 0001213900-24-090765
2024-10-04
Form 8-K
ID: 0001213900-24-085641
2024-09-10
Form 8-K
ID: 0001213900-24-077411
2024-09-10
Form 10-Q
ID: 0000950170-24-105016
2024-09-10
Form 10-Q
ID: 0000950170-24-105004
2024-07-17
Form 8-K
ID: 0001213900-24-062226
2024-07-03
Form 8-K
ID: 0001213900-24-058821
2024-05-28
Form 8-K
ID: 0001213900-24-047151
2024-02-26
Form 8-K
ID: 0001213900-24-016715
2023-12-20
Form 8-K
ID: 0001213900-23-097059